DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT
Dead / Abandoned — Abandoned — failure to respond (as of 09 Mar 2020)
What this means for you
This application is over — abandoned 25 Feb 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88451500
- Mark type
- Design + words
- Filed
- 29 May 2019
- Abandoned
- 25 Feb 2020
- Attorney of record
- Christopher J. McHattie, Esq.
Goods and services
- Class 036 — Insurance and financial services: Financial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy; Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payer reimbursement for prescription drugs
Owner
- Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, US
Prior registrations
Prosecution history
- 09 Mar 2020 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 09 Mar 2020 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 22 Aug 2019 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 22 Aug 2019 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 22 Aug 2019 — COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
- 22 Aug 2019 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
- 19 Aug 2019 — ASSIGNED TO EXAMINER
- 14 Jun 2019 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 13 Jun 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Jun 2019 — NEW APPLICATION ENTERED